Sign in

You're signed outSign in or to get full access.

Ellen Cooper

Ellen Cooper

Chief Executive Officer at LINCOLN NATIONALLINCOLN NATIONAL
CEO
Executive
Board

About Ellen Cooper

Ellen G. Cooper, age 60, has served as LNC’s Chairman since May 2023 and President & CEO since May 2022; she joined LNC in 2012 as EVP & Chief Investment Officer and later led Enterprise Risk and Annuity Solutions . Under her tenure, LNC improved its risk-based capital (RBC) to over 430% and achieved a 24.8% one-year total shareholder return in 2024, while divesting wealth management to add approximately $650M in statutory capital benefit . Long-term PSAs for the 2022–2024 cycle paid 0% (Operating ROE 10.8% vs threshold 13.79% and last in peer TSR at -42.53%), underscoring tightened pay-for-performance alignment going forward .

Past Roles

OrganizationRoleYearsStrategic Impact
Lincoln National CorporationChairman, President & CEO2023–present (Chair), 2022–present (CEO/President)Combined Chair/CEO leadership with Lead Independent Director oversight; execution on capital rebuild, operating model optimization, and profitable growth
Lincoln National CorporationEVP & Chief Investment Officer2012–2021Led investments; positioned capital and risk programs pre-CEO transition
Lincoln National CorporationHead of Enterprise Risk; led Annuity Solutions Group2019–2022; 2021–2022Centralized enterprise risk; advanced annuity strategy toward spread-based mix
Lincoln Variable Insurance Products TrustChair of the Board2015–2021Oversight of sponsored mutual funds for variable life/annuity products

External Roles

OrganizationRoleYearsStrategic Impact
American Council of Life Insurers (ACLI)Co-chair, Steering Committee on Prudential Issues; Member of Executive Committee & BoardCurrentIndustry capital/prudential standards influence and advocacy
Alliance for Lifetime IncomeBoard MemberCurrentRetirement income education and product advocacy
Public company boardsNoneNo external public board conflicts

Fixed Compensation

Metric202220232024
Base Salary ($)1,056,783 1,144,231 1,197,885
Target Bonus ($)2,320,313 (AIP target, pro-rata transition) 3,300,000 (AIP target)
Actual AIP Payout ($)1,276,172 3,845,009 4,705,800
Perquisites ($)353,536 403,555 576,882 (incl. personal security $23,050; aircraft personal use $18,471; charitable matching $10,000; executive physicals)

Notes:

  • Board advises CEO to use corporate aircraft for business and personal travel since 2005; personal use reported at incremental cost .
  • CEO receives no director fees .

Performance Compensation

2024 Annual Incentive Program (AIP) – CEO

MetricWeightTargetActualPayout (% of target)Vesting
Income from Operations per Share45% $6.70 $7.13 153.5% Annual cash
Life Insurance Sales & Capital Usage3.5% Sales $492M; Capital 100% Sales $492M; Capital 93.7% 100.0% Annual cash
Annuities Sales & Capital Usage5.5% Sales $13,000M; Capital 100% Sales $13,395M; Capital 95.3% 115.2% Annual cash
Group Protection Sales & Capital Usage4.0% Sales $720M; Capital 100% Sales $861M; Capital 122.2% 197.9% Annual cash
Retirement Plan Services Sales & Capital Usage2.0% Sales $13,283M; Capital 100% Sales $14,738M; Capital 105.5% 154.8% Annual cash
Enterprise Controllable Costs15% 100% 95.5% 109.7% Annual cash
Actions to Improve Distributable Earnings15% Qualitative plan Achieved (sale of wealth mgmt ~$650M capital; Bermuda affiliate reinsurance; leverage reduction, workforce actions) 175.0% Annual cash
Strategic Priorities10% Qualitative plan Achieved (brand relaunch; Life transformation; Workplace ops efficiency; finance/product governance; HCM process) 100.0% Annual cash

Total CEO AIP payout percentage: 142.6%; Actual AIP payout: $4,705,800 .

Long-Term Incentives (LTI)

  • 2024 LTI mix: 60% PSAs; 40% RSUs; options discontinued in 2024 .
  • PSA metrics (2024–2026 cycle): 50% Operating ROE (threshold 9.86%, target 11.60%, max 13.34); 50% Relative TSR (threshold 25th percentile, target 55th, max 80th; capped at 100% if absolute TSR is negative) . Max payout 200% after removal of DEI modifier in Feb 2025 .
AwardGrant DateThreshold (#)Target (#)Maximum (#)Vesting
PSAs (2024–2026)2/21/202424,185 (revised) 193,477 386,954 (revised) At end of cycle; payout 0%–200% per metrics
RSUs (2024 grant)2/21/2024128,985 3-year cliff (vests 2/21/2027)

Historical PSA outcome:

  • 2022–2024 PSAs paid 0% (Operating ROE 10.8%; Relative TSR last among peers with -42.53%) .

Equity Ownership & Alignment

ItemValue
Total beneficial ownership (common shares)494,299 shares (as of Mar 14, 2025)
Ownership as % of shares outstanding~0.29% (494,299 / 170,403,822 shares outstanding on Feb 13, 2025)
Options exercisable within 60 days351,345 shares (as of Mar 14, 2025)
Notable option strikes$73.51 and $57.16 (underwater at $39.09 on 2/14/2025)
Unvested RSUs (schedule)13,744 (2/16/2025); 8,660 (5/26/2025); 49,271 (2/15/2026); 134,596 (2/21/2027)
Outstanding PSAs (indicative)2023–2025 shown at target (~147,814 shares); 2024–2026 shown at maximum in table for disclosure; actual payout depends on cycle results
Ownership guidelinesCEO required to hold 7× base salary; executives prohibited from pledging/hedging; Ms. Cooper exceeds guideline as of Dec 31, 2024
10b5-1 and preclearanceRobust policy with cooling-off periods (≥90 days for Section 16 officers/directors), window periods, and transaction preclearance

Implication: Near-term “selling pressure” risk is modest given underwater option strikes and RSU cliff vesting cadence; policy restrictions further reduce opportunistic sales .

Employment Terms

ProvisionCEO Terms
Employment agreementNone; LNC does not use NEO employment agreements
Change-of-control (CoC) cash severance2.99× base salary + 2.99× target bonus; no tax gross-ups; payments subject to 280G cutback if beneficial
Non-CoC involuntary severance104 weeks (CEO) with stipend; contingent on release; offsets against any CoC severance
Equity treatment on CoCDouble-trigger; RSUs vest in full upon qualifying termination; PSAs generally paid for completed periods; open cycles paid at target and prorated unless Committee discretion applies
Equity treatment on retirement/death/disabilityRSUs vest; PSAs full non-prorated award in certain cases; detailed by award agreements
ClawbacksSEC/NYSE-compliant clawback adopted Nov 2023; equity awards include additional clawback/forfeiture covenants (non-compete/non-solicit/non-disparagement/confidentiality) lasting six months post-vesting
Deferred compensationSpecial executive credit equal to 5% of “Total Pay”; 2024 company contributions for Ms. Cooper: $486,510; DC SERP balance $4,501,852 (2024 year-end)

Board Governance

  • Combined Chair/CEO since May 2023; Lead Independent Director (W.H. Cunningham) with robust duties and executive session leadership .
  • Committees: Executive Committee Chair; sole member of Committee on Corporate Action (15 unanimous written consents in 2024) .
  • Independence: Not independent director; 9 of 10 nominees independent; all key committees chaired by independents .
  • Board meetings: Six in 2024; directors met ≥75% attendance; all attended 2024 AGM except Mr. Mee (health) .
  • Shareholder proposal: Recurrent proposal to separate Chair/CEO—46% support in 2023; Board recommends AGAINST in 2025, citing performance and governance structures .

Director Compensation (for completeness)

Directors (not including CEO) receive $110,000 cash retainer plus $180,000 in deferred stock units; Lead Independent Director receives $240,000 DSUs; committee chair/member fees per role; all outside directors met equity ownership guidelines (5× cash retainer) as of Dec 31, 2024 .

Compensation Structure Analysis

  • Mix shifts: Options discontinued in 2024; more RSUs and PSAs—reduces leverage and repricing risk; PSAs retain rigorous performance link .
  • AIP rigor: Heavier weighting on Income from Ops per Share (45%) and Controllable Costs (15%); balanced sales/capital usage modifiers—aligns with profitable growth and capital protection .
  • LTI metrics: Above-median TSR (55th percentile) required for target; negative TSR cap limits payouts—tightens alignment to shareholder outcomes .
  • Outcomes: 2024 AIP above target; 2022–2024 PSAs at 0%—clear differentiation between short-term operating execution and long-term value creation .

Say-on-Pay & Shareholder Feedback

Say-on-Pay approval was 84% in 2024; shareholder outreach reached investors representing 54% of shares and engaged with ~38%—feedback helped adjust program (TSR cap, PSA mix, severance policy) .

Performance & Track Record

  • 2024 Business highlights: Record Group Protection margins (8.3%), Annuities earnings +8%, RPS deposits +25% and 10th year positive flows; Life repositioning and distribution realignment .
  • Capital & risk: Sale of wealth management (~$650M statutory capital), RBC ratio >430% vs 420% buffer target; establishment of Bermuda affiliate reinsurer .
  • TSR: One-year TSR +24.8% in 2024; 2022–2024 TSR -42.53% (PSA cycle), reinforcing need for sustained execution .

Investment Implications

  • Alignment: Pay structure penalized long-term underperformance (0% PSAs) and rewarded 2024 operating execution (AIP > target), with clawbacks, double-trigger equity, and no tax gross-ups—reduces governance risk .
  • Selling pressure: Underwater options plus RSU cliff vesting and 10b5-1 restrictions moderate near-term insider selling risk; CEO exceeds ownership guideline and cannot pledge/hedge .
  • Dual role governance: Combined Chair/CEO persists with strong Lead Independent Director framework; continued investor attention likely given prior 46% support for separation .
  • Execution focus: Capital rebuild (RBC >430%), reinsurance capabilities, product mix shifts, and cost controls reflect durable improvement vectors; PSA metrics (ROE/Relative TSR) set a high bar for sustained value creation .